ENDRA Life Sciences Inc
NASDAQ:NDRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lotus Bakeries NV
XBRU:LOTB
|
BE |
ENDRA Life Sciences Inc
Other Liabilities
ENDRA Life Sciences Inc
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
Other Liabilities
$842.7k
|
CAGR 3-Years
32%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Liabilities
$2.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-2%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Liabilities
$2.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Liabilities
$7.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
5%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Other Liabilities
$189.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
2%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Liabilities
$510.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
18%
|
|
ENDRA Life Sciences Inc
Glance View
ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 22 full-time employees. The company went IPO on 2017-06-28. The firm has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of various other medical conditions. Its TAEUS technology platform application focuses on quantifying fat in the liver and stage progression of non-alcoholic fatty liver disease (NAFLD), which untreated, can progress to Non-alcoholic Steatohepatitis (NASH), fibrosis, cirrhosis, and liver cancer. The firm's TAEUS platform has various clinical applications, such as tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
See Also
What is ENDRA Life Sciences Inc's Other Liabilities?
Other Liabilities
842.7k
USD
Based on the financial report for Dec 31, 2025, ENDRA Life Sciences Inc's Other Liabilities amounts to 842.7k USD.
What is ENDRA Life Sciences Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
26%
Over the last year, the Other Liabilities growth was -35%. The average annual Other Liabilities growth rates for ENDRA Life Sciences Inc have been 32% over the past three years , 26% over the past five years .
